NeoImmuneTech, Inc. (NIT) is a biotech company developing T cell-centered novel immunotherapeutics. NIT Pioneers Next Generation Cancer Immunotherapeutics Technology: NIT’s lead product is Hyleukin-7(TM*), an engineered T cell amplifier designed to reconstitute and enhance antitumoral T cell immunity. Hyleukin-7(TM) consists of homodimeric Interleukin-7 (IL-7) molecules, which are homeostatic cytokines that enhance the numbe...
NeoImmuneTech, Inc. (NIT) is a biotech company developing T cell-centered novel immunotherapeutics. NIT Pioneers Next Generation Cancer Immunotherapeutics Technology: NIT’s lead product is Hyleukin-7(TM*), an engineered T cell amplifier designed to reconstitute and enhance antitumoral T cell immunity. Hyleukin-7(TM) consists of homodimeric Interleukin-7 (IL-7) molecules, which are homeostatic cytokines that enhance the number and function of T cells, biologically fused to IgD/IgG4 immunoglobulin domain (hyFc®) as a safe and effective long-acting carrier.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.